StockMacro
Menu

Tectonic Therapeutic

$20.73 -31% in 6 monthsMarket cap $405.3M

TECX on XNAS, Health Care, Tectonic Therapeutic, Inc., job postings

Measures activity, not value. Not investment advice.

Short interest 12% of shares with 13.7 days to cover, as institutional holders fell from 123 to 114.

  • BadNet loss of $88.1M over 12 months, with $234.7M cash

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
60
Website
tectonictx.com
Listed
Nasdaq, US
Last results
6 Aug 2026
Next results
no estimate
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $21.3M.
Quarter to 31 Dec 2021: revenue –, net income -$28.2MQuarter to 31 Mar 2022: revenue –, net income -$29.8MQuarter to 30 Jun 2022: revenue –, net income -$28.1MQuarter to 30 Sep 2022: revenue –, net income -$23.0MQuarter to 31 Dec 2022: revenue –, net income -$25.0MQuarter to 31 Mar 2023: revenue –, net income -$25.0MQuarter to 30 Jun 2023: revenue –, net income $67.5MQuarter to 30 Sep 2023: revenue –, net income -$21.6MQuarter to 31 Dec 2023: revenue –, net income -$8.8MQuarter to 31 Mar 2024: revenue –, net income -$6.8MQuarter to 30 Jun 2024: revenue –, net income -$12.7MQuarter to 30 Sep 2024: revenue –, net income -$17.7MQuarter to 31 Mar 2025: revenue –, net income -$15.9MQuarter to 30 Jun 2025: revenue –, net income -$20.0MQuarter to 30 Sep 2025: revenue –, net income -$19.0MQuarter to 31 Dec 2025: revenue –, net income -$19.2MQuarter to 31 Mar 2026: revenue –, net income -$25.2MQuarter to 30 Jun 2026: revenue –, net income -$22.3MQuarter to 30 Sep 2026: revenue –, net income -$21.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $67.5M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$21.3M
30 Jun 2026–-$22.3M
31 Mar 2026–-$25.2M
31 Dec 2025–-$19.2M
30 Sep 2025–-$19.0M
30 Jun 2025–-$20.0M
31 Mar 2025–-$15.9M
30 Sep 2024–-$17.7M
30 Jun 2024–-$12.7M
31 Mar 2024–-$6.8M
31 Dec 2023–-$8.8M
30 Sep 2023–-$21.6M
30 Jun 2023–$67.5M
31 Mar 2023–-$25.0M
31 Dec 2022–-$25.0M
30 Sep 2022–-$23.0M
30 Jun 2022–-$28.1M
31 Mar 2022–-$29.8M
31 Dec 2021–-$28.2M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$88.1M -$67.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$4.63 $6.66
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -35.5% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $234.7M $268.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $11.50
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.8 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Tectonic TherapeuticTECX (this company) $405.3Mloss–––
TevogenTVGN $405.2Mloss–––
Candel TherapeuticsCADL $395.4Mloss–––
IRulya TherapeuticsIRLA $432.4Mloss–––
Fennec PharmaceuticalsFENC $462.1M2287.0+71%3.1%
AlectorALEC $347.6M8.42.0+151%23.9%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$14K

bought $0, sold $14K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-7.3%

114 13F filers vs 123

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

72%

14.3M shares held by 13F filers (30 Sep 2026) of 19.9M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

12%

2.4M shares sold short (30 Oct 2026) of 19.9M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

13.7

2.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+6.8%

2.2M shares sold short in the report before, 2.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

71%

71% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

0

0 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

0 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $20.73 on 20 Nov 2026, +15% over 12 months (12-month range $17.93 to $37.93)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $469K in the last 12 months (the 12 months before: $42.5M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
Capital spending per quarter. Capital spending $79K in the latest quarter.
Institutional holders (13F filers). 114 13F filers reported holding it in the latest 13F quarter, +18% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
5 Nov 20268-K and other filingsCompleted an acquisition or asset sale
23 Apr 20268-K and other filingsDirector or officer change
24 Feb 20268-K and other filingsDirector or officer change
24 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Dec 2025Sharp changeShort interest spike: short interest spike, 5.4M vs usual 1.4M (2025-12-15); 10.5x the same period a year earlier
16 Dec 2025Sharp changeShort interest spike: short interest spike, 5.1M vs usual 1.3M (2025-11-28); 10.7x the same period a year earlier
2 Dec 2025Sharp changeShort interest spike: short interest spike, 5.0M vs usual 1.3M (2025-11-14); 11.4x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 4.8M vs usual 1.2M (2025-10-31); 13.6x the same period a year earlier
26 Mar 20258-K and other filingsRegistered new securities for sale (S-1)
14 Feb 20258-K and other filingsPrivate placement of securities (Form D)
19 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
5 Jul 20248-K and other filingsDirector or officer change
20 Jun 20248-K and other filingsDirector or officer change
20 Jun 20248-K and other filingsChanged its auditor
20 Jun 20248-K and other filingsCompleted an acquisition or asset sale
20 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jan 20248-K and other filingsDirector or officer change
30 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Jul 20238-K and other filingsRestructuring costs announced
12 Jun 20238-K and other filingsDirector or officer change
12 Jun 20238-K and other filingsCompleted an acquisition or asset sale
12 Jun 20238-K and other filingsA major agreement ended
9 Jun 20238-K and other filingsDirector or officer change
22 May 20238-K and other filingsRestructuring costs announced
1 May 20238-K and other filingsDirector or officer change
1 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Oct 20228-K and other filingsDelisting notice or listing transfer
29 Jun 20228-K and other filingsDirector or officer change
29 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Jan 20228-K and other filingsDirector or officer change
7 Jan 20228-K and other filingsRestructuring costs announced
7 Jan 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 May 2024: $973K published
Month from 1 Sep 2024: $1.4M published
Month from 1 Oct 2024: $10.1M published
Month from 1 Feb 2025: $40.2M published
Month from 1 Apr 2025: $2.3M published
Month from 1 Feb 2026: $182K published
Month from 1 Mar 2026: -$567K published
Month from 1 Apr 2026: -$31K published
Month from 1 May 2026: -$32K published
Month from 1 Jul 2026: -$6K published
Month from 1 Aug 2026: -$3K published
Month from 1 Oct 2026: -$12K published
H-1B/E-3 applications certified
Quarter from 1 Jul 2022: 1 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Oct 2026: 1 published
Capital spending per quarter
Quarter ended 31 Dec 2021: $850K, +949% on a year earlier; public on 18 Mar 2022
Quarter ended 31 Mar 2022: $32K, -72% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $149K, -88% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $86K, -68% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Mar 2023: $8K, -75% on a year earlier; public on 12 May 2023
Quarter ended 30 Jun 2023: $0, -100% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $0, -100% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $0; public on 15 Mar 2024
Quarter ended 31 Mar 2024: $0, -100% on a year earlier; public on 10 May 2024
Quarter ended 31 Mar 2025: $27K; public on 9 May 2025
Quarter ended 30 Sep 2025: $181K; public on 7 Nov 2025
Quarter ended 31 Mar 2026: $19K, -30% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $79K; public on 7 Aug 2026
Institutional holders (13F filers)
30 Jun 2024 report: 38; public on 14 Aug 2024
30 Sep 2024 report: 51; public on 14 Nov 2024
31 Dec 2024 report: 69; public on 14 Feb 2025
31 Mar 2025 report: 76; public on 15 May 2025
30 Jun 2025 report: 76; public on 14 Aug 2025
30 Sep 2025 report: 97; public on 14 Nov 2025
31 Dec 2025 report: 102; public on 17 Feb 2026
31 Mar 2026 report: 106; public on 15 May 2026
30 Jun 2026 report: 123; public on 14 Aug 2026
30 Sep 2026 report: 114; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is total debt at period end: short- and long-term borrowings at $15.0M (31 Mar 2023), higher than 100% of its own history.
  • Insider net buying (open market): Insiders sold a net $469K in the last 12 months (the 12 months before: $42.5M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
  • Capital spending per quarter: Capital spending $79K in the latest quarter.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 30 insider trades

Last 90 days: 2 sales, $14K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
2 Oct 2026Peter McNamaraChief Scientific OfficerSellplanned in advance (10b5-1)536$23.04$12KForm 4
26 Aug 2026Peter McNamaraChief Scientific OfficerSellplanned in advance (10b5-1); after exercising options43$36.52$2KForm 4
14 Aug 2026Peter McNamaraChief Scientific OfficerSellplanned in advance (10b5-1); after exercising options43$35.00$2KForm 4
1 Jul 2026Peter McNamaraChief Scientific OfficerSellplanned in advance (10b5-1); after exercising options172$35.00$6KForm 4
6 May 2026Marcella K. RuddyChief Medical OfficerSellplanned in advance (10b5-1)1,065$30.00$32KForm 4
3 Apr 2026Marcella K. RuddyChief Medical OfficerSellplanned in advance (10b5-1)1,000$31.05$31KForm 4
9 Mar 2026Peter McNamaraChief Scientific OfficerSellplanned in advance (10b5-1); after exercising options6,262$30.17$189KForm 4
9 Mar 2026Marcella K. RuddyChief Medical OfficerSellplanned in advance (10b5-1)10,000$30.00$300KForm 4

114 institutions reported shares at the end of Q3 2026, 72% of the shares outstanding; 12 opened a position, 20 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
FMR LLC (Fidelity)2.9M14.7%$68.3M+102K+3.6%
TCG Crossover Management, LLC1.2M6.04%$28.1MNo change
BlackRock, Inc.861K4.31%$20.0M-1,856-0.2%
Baker Bros. Advisors LP608K3.05%$14.2MNo change
5AM Venture Management, LLC607K3.04%$14.1MNo change
Vanguard Capital Management LLC512K2.57%$11.9M+24K+4.8%
First Light Asset Management, LLC496K2.49%$11.6M-305K-38%
Aberdeen Group plc485K2.43%$11.3M-657K-58%
Marshall Wace, LLP447K2.24%$10.4M+274K+159%
Braidwell LP371K1.86%$8.6M-226K-38%

Company events

All 40 company events

In 12 months: 2 director or officer changes, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
5 Nov 2026Completed an acquisition or asset sale8-K
23 Apr 2026Director or officer change8-K
24 Feb 2026Director or officer change8-K
26 Mar 2025Registered new securities for sale (S-1)S-1
14 Feb 2025Private placement of securities (Form D)$185.0M sold of $185.0M offeredD
3 Feb 2025Signed a major agreementSame filing: sold shares privately8-K
19 Jul 2024Registered new securities for sale (S-1)S-1
5 Jul 2024Director or officer change8-K

The 5 newest of 45 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 5 Nov 2026Filings record

    Completed an acquisition or asset sale

  2. 23 Apr 2026Filings record

    Director or officer change

  3. 6 Mar 2026Insiders record

    REICIN ALISE (Chief Executive Officer) bought 2,500 shares of TECX ($52,750) [amended] (dated 5 Mar 2026)

  4. 24 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 24 Feb 2026Filings record

    Director or officer change

  6. 13 Feb 2026Insiders record

    REICIN ALISE (Chief Executive Officer) bought 2,500 shares of TECX ($52,750) (dated 12 Feb 2026)

  7. 12 Feb 2026Insiders record

    Lochner Daniel (Chief Financial Officer) bought 6,000 shares of TECX ($129,660) (dated 11 Feb 2026)

  8. 25 Dec 2025Short interest and volume change

    had 5.4M shares sold short in the 15 Dec 2025 report, 10× the same report last year.

    Same report last year: 512K; its normal report is 1.4M.

    See the evidence
    This period
    5.4M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    645K
    How far from its usual level
    +4.1
    Same report last year
    512K
    History used
    535 days
    2024-12-13: 512K2024-12-31: 571K2025-01-15: 661K2025-01-31: 1.1M2025-02-14: 888K2025-02-28: 945K2025-03-14: 882K2025-03-31: 1.1M2025-04-15: 1.5M2025-04-30: 1.2M2025-05-15: 1.3M2025-05-30: 1.3M2025-06-13: 1.3M2025-06-30: 1.8M2025-07-15: 1.9M2025-07-31: 2.2M2025-08-15: 2.5M2025-08-29: 2.6M2025-09-15: 2.4M2025-09-30: 2.8M2025-10-15: 3.6M2025-10-31: 4.8M2025-11-14: 5.0M2025-11-28: 5.1M2025-12-15: 5.4M
    the 15 Dec 2025 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 10 Dec 2025Short interest and volume change

    had 5.1M shares sold short in the 28 Nov 2025 report, 11× the same report last year.

    Same report last year: 477K; its normal report is 1.3M.

    See the evidence
    This period
    5.1M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    631K
    How far from its usual level
    +4.0
    Same report last year
    477K
    History used
    518 days
    2024-11-29: 477K2024-12-13: 512K2024-12-31: 571K2025-01-15: 661K2025-01-31: 1.1M2025-02-14: 888K2025-02-28: 945K2025-03-14: 882K2025-03-31: 1.1M2025-04-15: 1.5M2025-04-30: 1.2M2025-05-15: 1.3M2025-05-30: 1.3M2025-06-13: 1.3M2025-06-30: 1.8M2025-07-15: 1.9M2025-07-31: 2.2M2025-08-15: 2.5M2025-08-29: 2.6M2025-09-15: 2.4M2025-09-30: 2.8M2025-10-15: 3.6M2025-10-31: 4.8M2025-11-14: 5.0M2025-11-28: 5.1M
    the 28 Nov 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 26 Nov 2025Short interest and volume change

    had 5.0M shares sold short in the 14 Nov 2025 report, 11× the same report last year.

    Same report last year: 439K; its normal report is 1.3M.

    See the evidence
    This period
    5.0M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    631K
    How far from its usual level
    +4.0
    Same report last year
    439K
    History used
    504 days
    2024-11-15: 439K2024-11-29: 477K2024-12-13: 512K2024-12-31: 571K2025-01-15: 661K2025-01-31: 1.1M2025-02-14: 888K2025-02-28: 945K2025-03-14: 882K2025-03-31: 1.1M2025-04-15: 1.5M2025-04-30: 1.2M2025-05-15: 1.3M2025-05-30: 1.3M2025-06-13: 1.3M2025-06-30: 1.8M2025-07-15: 1.9M2025-07-31: 2.2M2025-08-15: 2.5M2025-08-29: 2.6M2025-09-15: 2.4M2025-09-30: 2.8M2025-10-15: 3.6M2025-10-31: 4.8M2025-11-14: 5.0M
    the 14 Nov 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 13 Nov 2025Short interest and volume change

    had 4.8M shares sold short in the 31 Oct 2025 report, 14× the same report last year.

    Same report last year: 355K; its normal report is 1.2M.

    See the evidence
    This period
    4.8M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    619K
    How far from its usual level
    +3.9
    Same report last year
    355K
    History used
    490 days
    2024-10-31: 355K2024-11-15: 439K2024-11-29: 477K2024-12-13: 512K2024-12-31: 571K2025-01-15: 661K2025-01-31: 1.1M2025-02-14: 888K2025-02-28: 945K2025-03-14: 882K2025-03-31: 1.1M2025-04-15: 1.5M2025-04-30: 1.2M2025-05-15: 1.3M2025-05-30: 1.3M2025-06-13: 1.3M2025-06-30: 1.8M2025-07-15: 1.9M2025-07-31: 2.2M2025-08-15: 2.5M2025-08-29: 2.6M2025-09-15: 2.4M2025-09-30: 2.8M2025-10-15: 3.6M2025-10-31: 4.8M
    the 31 Oct 2025 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 12 Apr 2025Insiders record

    SPRINGER TIMOTHY A (director) bought 141,923 shares of TECX ($2.3M) (dated 11 Apr 2025)

  13. 10 Apr 2025Insiders record

    SPRINGER TIMOTHY A (director) bought 500,000 shares of TECX ($8.6M) (dated 9 Apr 2025)

  14. 26 Mar 2025Filings record

    Registered new securities for sale (S-1)

  15. 14 Feb 2025Filings record

    Private placement of securities (Form D)

  16. 8 Feb 2025Insiders record

    Lochner Daniel (Chief Financial Officer) bought 4,617 shares of TECX ($249,964) (dated 7 Feb 2025)

  17. 8 Feb 2025Insiders record

    SPRINGER TIMOTHY A (director) bought 789,294 shares of TECX ($40.0M) (dated 7 Feb 2025)

  18. 25 Oct 2024Insiders record

    SPRINGER TIMOTHY A (director) bought 300,000 shares of TECX ($10.1M) (dated 24 Oct 2024)

  19. 27 Sep 2024Insiders record

    SPRINGER TIMOTHY A (director) bought 50,000 shares of TECX ($1.4M) (dated 26 Sep 2024)

  20. 19 Jul 2024Filings record

    Registered new securities for sale (S-1)

  21. 5 Jul 2024Filings record

    Director or officer change

  22. 20 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 20 Jun 2024Filings record

    Director or officer change

  24. 20 Jun 2024Filings record

    Changed its auditor

  25. 20 Jun 2024Filings record

    Completed an acquisition or asset sale

  26. 16 May 2024Insiders record

    Leonard Braden Michael (ten percent owner) bought 766,635 shares of AVRO ($972,761) (dated 15 May 2024)

  27. 30 Jan 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 30 Jan 2024Filings record

    Director or officer change

  29. 12 Jul 2023Filings record

    Restructuring costs announced

  30. 12 Jun 2023Filings record

    Director or officer change

  31. 12 Jun 2023Filings record

    Completed an acquisition or asset sale

  32. 12 Jun 2023Filings record

    A major agreement ended

  33. 9 Jun 2023Filings record

    Director or officer change

  34. 22 May 2023Filings record

    Restructuring costs announced

  35. 1 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 1 May 2023Filings record

    Director or officer change

  37. 7 Oct 2022Filings record

    Delisting notice or listing transfer

  38. 29 Jun 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 29 Jun 2022Filings record

    Director or officer change

  40. 7 Jan 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 58 entries; narrow the window or the kind of data to see older ones.

Not listed: 123 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001681087
Ticker
TECX
Domain
tectonictx.com
Employer name
Tectonic Operating Company, Inc., Tectonic Therapeutic, Inc. (2 unverified)
Fein
84-2595003 (1 unverified)
Hq location
MA|WATERTOWN| (1 unverified)
Name
AVROBIO Australia Pty Ltd, AvroBio, Inc., Tectonic Operating Company, Inc, Tectonic Therapeutic, Inc. and 1 more
  • DOL H-1B labor condition applications and PERM certifications22 data points9 May 2022 to 7 Sep 2026
  • SEC Form 13F institutional holdings90 data points30 Jun 2024 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)140 records3 Aug 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)466 data points31 Dec 2016 to 30 Oct 2026
  • SEC Form 4 insider transactions30 records, 96 data points9 Apr 2019 to 2 Oct 2026
  • FINRA short interest (twice monthly)171 data points28 Jun 2024 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)1216 data points21 Jun 2024 to 20 Nov 2026